Glenview Capital Management

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Detect they build tools that empower people to understand their health.

Limber Health is a healthcare technology company focused on enhancing musculoskeletal (MSK) care through a hybrid model that integrates both in-person and digital solutions. Developed by physical therapists and physicians, the platform offers a comprehensive digital toolkit that includes remote therapeutic monitoring, home exercise programs, outcomes collection, and care navigation tools for managing musculoskeletal conditions. The effectiveness of Limber's approach has been clinically validated through research at Mayo Clinic, and the company has received recognition for its significant impact on rehabilitation technology. By augmenting traditional clinician visits with digital support, Limber Health aims to improve patient outcomes and facilitate a shift toward value-based care in the healthcare system.

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Quantum-Si is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

Identifeye is creating prediction models that combine multiple retinal imaging modalities with expert annotations to create comprehensive and non-invasive health assessments. Identifeye Health is a part of the 4Catalyzer accelerator, which is dedicated to improving patient care globally. It has offices in Guilford, Connecticut, New York City, and Palo Alto, California.

Butterfly Network, Inc. is a medical imaging company based in Guilford, Connecticut, that specializes in handheld ultrasound technology. Founded in 2011, the company has developed the world's first handheld, single-probe whole-body ultrasound system, known as Butterfly iQ, powered by its proprietary Ultrasound-on-Chip technology. This innovative device provides diagnostic imaging for various medical conditions affecting the cardiac, abdominal, urological, fetal, gynecological, and musculoskeletal systems. Butterfly Network aims to democratize access to medical imaging, particularly for the 4.7 billion people globally who lack access to ultrasound services. By integrating cloud-connected software with its ultrasound hardware, Butterfly enhances the clinical workflow, facilitating earlier detection and remote management of health conditions.

SunEdison is a global energy solutions provider, specializing in solar power. The company offers a comprehensive range of services, from design and installation to maintenance, catering to residential, commercial, and utility customers. SunEdison's expertise lies in developing, financing, and operating renewable power plants, delivering reliable and cost-effective energy solutions tailored to each client's unique needs.

Calypso Medical Technologies is a Seattle-based medical device company that specializes in real-time localization technology for tumor tracking. Its proprietary system employs miniaturized implanted devices, known as Beacon electromagnetic transponders, to continuously and accurately monitor the location of tumors. This innovative approach aims to enhance the precision and management of radiation therapy delivery, particularly for body-wide cancers commonly treated with this method. The company's products have received FDA 510(k) clearance for use in the prostate and post-operative prostatic bed. Calypso Medical has established strategic partnerships with major industry players, including Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.